Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRVL
CRVL logo

CRVL Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
60.169
Open
59.810
VWAP
59.13
Vol
197.88K
Mkt Cap
2.99B
Low
58.340
Amount
11.70M
EV/EBITDA(TTM)
16.16
Total Shares
50.69M
EV
2.83B
EV/OCF(TTM)
18.15
P/S(TTM)
3.25
CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner.
Show More

Events Timeline

(ET)
2026-06-01
16:40:00
CorVel Appoints Sarah Scott as CEO
select
2026-05-20 (ET)
2026-05-20
06:20:00
Q4 Revenue Reaches $248.54M
select
2026-02-03 (ET)
2026-02-03
06:20:00
Q3 Revenue Reaches $236M vs. $228M Last Year
select
2025-02-13 (ET)
2025-02-13
06:36:59
CorVel appoints Scott as Executive Vice President of Product
select
2024-12-24 (ET)
2024-12-24
12:16:10
CorVel announces effectiveness of three-for-one forward stock split
select
2024-12-13 (ET)
2024-12-13
15:17:39
CorVel announces three-for-one forward stock split
select
2024-11-29 (ET)
2024-11-29
12:31:08
CorVel chairman Clemons to retire, CEO Combs named next chairman
select
2024-08-27 (ET)
2024-08-27
07:43:28
CERIS announces advancements to FWA solutions
select

News

Newsfilter
7.5
11:43 AMNewsfilter
CorVel Launches Market-Based Medical Bill Repricing Solution
  • Innovative Bill Repricing: CorVel Corporation's newly launched Marketwise Repricing™ solution integrates market-based pricing methods to enhance cost containment in medical bill reviews, providing a more effective solution when traditional methods fall short.
  • Increased Market Adaptability: By utilizing real-world reimbursement data, the solution ensures pricing outcomes better reflect local market conditions, particularly useful for out-of-network bills and in states with limited fee schedules, thereby enhancing clients' cost management capabilities.
  • Seamless Workflow Integration: Marketwise Repricing integrates smoothly with existing bill review programs, ensuring end-to-end management while reducing administrative burdens, thus enhancing the effectiveness of existing strategies and offering alternatives for complex or high-variance billing scenarios.
  • Strategic Implications: By delivering more supportable pricing outcomes, CorVel not only strengthens its competitive position in the medical bill management sector but also provides clients with more flexible cost control measures to adapt to the evolving landscape of healthcare expenses.
Newsfilter
8.5
06-02Newsfilter
CorVel Corporation Celebrates 35th Anniversary as a Public Company
  • 35th Anniversary Celebration: CorVel Corporation will ring the Nasdaq opening bell in New York City on June 9, 2026, marking its 35th anniversary as a public company, highlighting its sustained influence and stability in the market.
  • Strong Financial Performance: Fiscal year 2026 represents a pivotal moment for CorVel, as the company continues to achieve market momentum through technology investments and operational discipline, strengthening partnerships and boosting stakeholder confidence.
  • Commitment to Long-Term Value: CEO Michael Combs stated that this milestone reflects the company's ongoing efforts in execution, investment, and market adaptability, indicating CorVel's dedication to long-term value creation in the years ahead.
  • Technology-Driven Services: CorVel applies technologies such as artificial intelligence, machine learning, and natural language processing to enhance healthcare management efficiency, supporting partners like employers and insurance companies, showcasing its innovative capabilities in health and workers' compensation sectors.
seekingalpha
5.0
06-01seekingalpha
CorVel Appoints New CEO and President
  • Executive Transition: CorVel announced that Sarah Scott will become CEO and President effective July 1, 2026, succeeding Michael Combs, who has served as President since 2017 and CEO since 2019, indicating a strategic leadership shift within the company.
  • Leadership Experience: Scott has over 26 years of experience at CorVel and currently serves as Executive Vice President of Product and Corporate Services, which positions her well to leverage her extensive industry knowledge for future business growth.
  • Growth and Development: Under Combs' leadership, CorVel has experienced significant growth and strategic development, reflecting the company's ongoing enhancement of its operational capabilities and market position.
  • Future Outlook: The appointment of the new CEO signals CorVel's commitment to advancing its strategic objectives, particularly in launching large payer programs and transitioning towards prepaid solutions, which is expected to further strengthen the company's competitive edge.
Newsfilter
5.0
06-01Newsfilter
CorVel Appoints New CEO and President
  • Leadership Transition: CorVel announced that Sarah Scott will become CEO and President effective July 1, 2026, succeeding Michael G. Combs, who has served as CEO since 2019 and will transition to Executive Chair, continuing to advance the company's long-term vision and strategic priorities.
  • Successor's Background: With over 26 years at CorVel, Sarah Scott currently serves as Executive Vice President of Product and Corporate Services, where she has played a crucial role in enhancing operational performance, customer relationships, and strategic initiatives, underscoring her importance in the leadership transition.
  • Board Support: Board member Jeff Michael stated that this leadership change reflects the strength of the leadership team and the company's long-term succession planning, emphasizing that Sarah is well-positioned to guide CorVel into its next growth phase.
  • Future Outlook: Sarah Scott expressed her eagerness to lead CorVel, highlighting the exceptional team and culture in place, and her commitment to strengthening market leadership and delivering meaningful value for partners, team members, and shareholders, showcasing confidence in the company's future.
NASDAQ.COM
8.5
05-24NASDAQ.COM
Owls Nest Acquires Additional Shares in CorVel
  • Share Acquisition: Owls Nest acquired 348,329 shares of CorVel in Q1 2026, with an estimated trade value of $20.06 million, indicating confidence in the company despite recent stock declines.
  • AUM Growth: This transaction resulted in a 7.02% increase in Owls Nest's 13F reportable AUM, reflecting the effectiveness of its investment strategy in the healthcare management sector.
  • Financial Performance: CorVel reported a 7% revenue increase to $959 million for fiscal 2026, with diluted earnings per share rising 17%, showcasing strong performance in the insurance and risk management space.
  • Market Outlook: Growing demand for CorVel's healthcare payment accuracy platform, CERIS, is expected to provide greater revenue visibility, indicating that the company's strategic focus on innovation and operational efficiency is beginning to pay off.
Fool
8.5
05-24Fool
Owls Nest Partners Acquires New Position in CorVel
  • New Position Disclosure: On May 14, 2026, Owls Nest Partners IA disclosed a new holding of 348,329 shares of CorVel (CRVL), with an estimated transaction value of $20.06 million, reflecting confidence in the company's potential.
  • Asset Management Significance: CorVel now accounts for 6.66% of Owls Nest's reportable AUM, indicating its growing importance in the investment portfolio, which may influence future investment strategies.
  • Financial Performance: CorVel's fiscal 2026 revenue rose by 7% to $959 million, while diluted earnings per share increased by 17% to $2.14, demonstrating the company's ability to grow even in challenging market conditions, attracting investor interest.
  • Market Outlook: Despite a 45% decline in stock price, CorVel has secured several large clients for its healthcare payment accuracy platform, CERIS, which is expected to enhance future revenue visibility, underscoring the company's competitiveness in healthcare cost management.

Valuation Metrics

The current forward P/E ratio for CorVel Corp (CRVL.O) is 23.75, compared to its 5-year average forward P/E of 94.47. For a more detailed relative valuation and DCF analysis to assess CorVel Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
94.47
Current PE
23.75
Overvalued PE
130.25
Undervalued PE
58.68

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
6.86
Current PS
0.00
Overvalued PS
8.79
Undervalued PS
4.93

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Qué acciones tienen el rsi por debajo de 30
Intellectia · 288 candidates
Region: USRsi Category: oversoldList Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
SMWB logo
SMWB
Similarweb Ltd
336.50M
SSKN logo
SSKN
Strata Skin Sciences Inc
1.86M
UGRO logo
UGRO
urban-gro Inc
2.43M
GSHD logo
GSHD
Goosehead Insurance Inc
1.87B
ENSC logo
ENSC
Ensysce Biosciences Inc
1.58M
SLND logo
SLND
Southland Holdings Inc
81.17M

Whales Holding CRVL

K
Kayne Anderson Rudnick Investment Management, LLC
Holding
CRVL
+1.92%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is CorVel Corp (CRVL) stock price today?

The current price of CRVL is 58.89 USD — it has decreased -2.4

What is CorVel Corp (CRVL)'s business?

CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner.

What is the price predicton of CRVL Stock?

Wall Street analysts forecast CRVL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRVL is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CorVel Corp (CRVL)'s revenue for the last quarter?

CorVel Corp revenue for the last quarter amounts to 248.55M USD, increased 7.36

What is CorVel Corp (CRVL)'s earnings per share (EPS) for the last quarter?

CorVel Corp. EPS for the last quarter amounts to 0.61 USD, increased 19.61

How many employees does CorVel Corp (CRVL). have?

CorVel Corp (CRVL) has 5239 emplpoyees as of June 17 2026.

What is CorVel Corp (CRVL) market cap?

Today CRVL has the market capitalization of 2.99B USD.